杭氧集团股份有限公司 2025 年第三季度报告 | 证券代码：002430 | 证券简称：杭氧股份 | 公告编号：2025-101 | | --- | --- | --- | | 转债代码：127064 | 转债简称：杭氧转债 | | 杭氧集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 杭氧集团股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 增减 | 上 ...

Financial Performance - The company's revenue for Q3 2025 was ¥334,686,849.16, a decrease of 4.59% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥1,752,000.08, an increase of 137.23% year-on-year, while the net profit after deducting non-recurring gains and losses was -¥6,110,957.58, a decrease of 62.13%[5]. - The basic earnings per share for the period was ¥0.0018, up 136.73% year-on-year[5]. - Total operating revenue for the current period reached ¥996,357,916.07, an increase of 5.0% compared to ¥939,956,746.25 in the previous period[20]. - The net profit for the current period was a loss of ¥12,777,476.47, an improvement from a loss of ¥55,695,104.00 in the previous period[21]. - The net profit attributable to the parent company was -6,916,421.61 CNY, compared to -56,719,680.51 CNY in the previous period[22]. - The total comprehensive income amounted to -9,833,502.10 CNY, down from -56,430,109.52 CNY year-over-year[22]. - The basic and diluted earnings per share were both -0.0072 CNY, compared to -0.0589 CNY in the previous period[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥4,145,198,667.21, reflecting a 3.14% increase from the end of the previous year[5]. - The total assets of the company increased to ¥4,145,198,667.21 from ¥4,019,170,670.70, marking a growth of 3.1%[17]. - Current liabilities rose to ¥1,774,722,283.44, up from ¥1,558,601,363.22, representing an increase of 13.8%[17]. - The total liabilities of the company increased to ¥2,011,507,122.69 from ¥1,875,453,209.03, reflecting a growth of 7.2%[17]. - The company's total equity decreased to ¥2,133,691,544.52 from ¥2,143,717,461.67, a decline of 0.5%[17]. Cash Flow - Cash flow from operating activities showed a net inflow of ¥5,039,810.55, a significant decrease of 94.44% compared to the previous year[5]. - Operating cash flow generated was 5,039,810.55 CNY, a significant decrease from 90,596,629.86 CNY in the previous period[24]. - Cash inflow from operating activities totaled 965,813,689.67 CNY, compared to 927,195,314.12 CNY last year[24]. - Cash outflow from operating activities was 960,773,879.12 CNY, up from 836,598,684.26 CNY in the previous period[24]. - Investment activities resulted in a net cash outflow of -82,047,974.01 CNY, compared to -88,144,766.95 CNY last year[25]. - Financing activities generated a net cash inflow of 162,729,697.72 CNY, reversing from a net outflow of -4,880,504.53 CNY in the previous period[25]. - The ending cash and cash equivalents balance was 409,464,265.46 CNY, an increase from 227,157,307.20 CNY at the end of the previous period[25]. - The company received 48,133,583.50 CNY in tax refunds, up from 39,729,171.92 CNY last year[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 52,662[10]. - The largest shareholder, Ningbo Yaben Holdings Co., Ltd., holds 26.75% of shares, totaling 257,729,839 shares, with 87,600,000 shares pledged[10]. - The second-largest shareholder, Wang Xinya, holds 6.75% of shares, totaling 65,000,350 shares, with 65,000,000 shares pledged[10]. - The total number of shares held by the top 10 shareholders includes significant pledges, indicating potential liquidity risks[10]. - The company has a total of 6,657,225 restricted shares that were released due to executive changes[12]. - The report indicates that there are no other known relationships among shareholders beyond those disclosed[10]. Strategic Initiatives - The company signed a strategic supply agreement with Jiangsu Hengrui Medicine Co., Ltd. on August 1, 2025, to enhance collaboration in pharmaceutical intermediates and active pharmaceutical ingredients[13]. - The company announced the termination of plans to acquire a stake in Gansu Haotian Technology Co., Ltd. on July 30, 2025[13]. - The company is focusing on innovation in the pharmaceutical CDMO business as part of its "2+X" strategy[13]. - The company has a strong emphasis on quality control and technological innovation in its operations[13]. Operational Costs - Total operating costs amounted to ¥1,026,893,621.09, slightly up from ¥1,022,711,059.09, indicating a marginal increase of 0.2%[21]. - Research and development expenses increased significantly to ¥86,247,119.60, up from ¥67,919,076.00, reflecting a growth of 27.0%[21]. Asset Management - The company reported a 334.80% increase in fair value changes, amounting to ¥10,885,655.91, primarily due to changes in other non-current financial assets[8]. - The company experienced a 16541.65% increase in asset disposal gains, totaling ¥9,670,874.25, indicating improved asset management[8]. - The company’s long-term borrowings decreased by 38.67% to ¥128,800,000.00, attributed to repayment efforts[8]. - The company’s contract liabilities increased by 88.67% to ¥15,871,737.09, indicating a rise in advance payments received[8]. - The company’s financial expenses decreased by 58.36% to ¥10,189,085.27, mainly due to the impact of exchange gains and losses[8].

Financial Performance - The company's revenue for Q3 2025 was CNY 2,175,292,094.32, a decrease of 16.71% year-on-year, while the total revenue for the first nine months was CNY 6,772,001,305.51, down 37.35% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2025 was CNY 287,726,544.56, an increase of 13.57% year-on-year, and for the first nine months, it was CNY 881,541,201.03, up 3.13% year-on-year[5]. - Total operating profit for the reporting period was CNY 1.082 billion, a decrease of 1.87% year-on-year, while net profit attributable to shareholders increased by 3.13% to CNY 0.882 billion[14]. - Revenue for the first nine months of 2025 was CNY 6.772 billion, a decrease of 37.35% compared to CNY 10.809 billion in the same period last year, primarily due to weak consumer demand[19]. - Total operating revenue for the current period is ¥6,772,001,305.51, a decrease of 37.3% compared to ¥10,808,649,102.64 in the previous period[30]. - Net profit for the current period is ¥879,994,204.29, an increase of 3.3% from ¥852,968,691.99 in the previous period[31]. - Earnings per share for the current period is ¥0.81, compared to ¥0.79 in the previous period[31]. Profitability and Margins - The gross profit margin improved to 29.74%, an increase of 9.16 percentage points year-on-year, benefiting from product structure optimization and pricing advantages due to rising gold prices[12]. - The company's gross profit margin improved significantly during the reporting period, reflecting successful structural adjustments and effective expense management[14]. Revenue Streams - E-commerce revenue grew by 17.68% year-on-year to CNY 19.45 billion, while franchise business revenue decreased by 56.34% to CNY 33.45 billion[10]. - The sales revenue from inlaid products was CNY 5.56 billion, a decrease of 4.89% year-on-year, while the revenue from pure gold products was CNY 49.42 billion, down 44.44%[9]. - The company reported a significant decline in revenue from self-operated offline business, which was CNY 13.42 billion, down 0.86% year-on-year[10]. Cost Management - The total expenses for the reporting period amounted to CNY 0.834 billion, a decrease of 10.74% year-on-year, indicating effective cost control measures[14]. - Total operating costs for the current period are ¥5,678,753,674.21, down 41.1% from ¥9,624,430,387.75 in the previous period[30]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 8,191,644,949.60, an increase of 4.54% compared to the end of the previous year[5]. - Total liabilities rose to ¥1,937,481,193.44, up 30.4% from ¥1,484,638,421.89 in the previous period[29]. - The total equity attributable to shareholders of the parent company decreased to ¥6,260,591,341.91 from ¥6,355,976,644.58, a decline of 1.5%[29]. Cash Flow - The net cash flow from operating activities decreased by 55.86% to CNY 580.45 million, attributed to a decline in operating income[20]. - Operating cash flow for the current period is ¥580,450,183.37, a decrease of 55.8% compared to ¥1,314,997,122.68 in the previous period[32]. - Total cash inflow from operating activities is ¥6,220,703,959.69, down 44.4% from ¥11,193,977,241.55 year-on-year[32]. - Cash outflow from operating activities is ¥5,640,253,776.32, a reduction of 42.5% compared to ¥9,878,980,118.87 in the previous period[32]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 30,653[23]. - The largest shareholder, Shenzhen Zhou's Investment Co., Ltd., holds 56.11% of shares, totaling 609,018,750 shares[23]. - The top ten shareholders hold a combined 82.54% of the shares, indicating a concentrated ownership structure[24]. Future Plans and Strategies - The company plans to continue focusing on multi-brand strategies and product innovation to adapt to market changes and enhance market share[8]. - The company plans to continue its strategy of "steady growth, improving gross profit, and controlling risks" into the fourth quarter of 2025[14]. - The company emphasized the development of lightweight, personalized, and high-cost performance products, which helped mitigate the demand weakness in traditional gold categories[8]. Other Financial Metrics - The weighted average return on equity was 4.50% for Q3 2025, a slight increase of 0.48 percentage points year-on-year[5]. - Research and development expenses for the current period are ¥8,258,258.84, slightly down from ¥8,909,429.39 in the previous period[30]. - The company reported an investment income of ¥49,145,330.72, compared to a loss of ¥79,784,224.24 in the previous period[30]. - The deferred income tax assets increased to ¥155,486,127.38 from ¥136,400,637.54, indicating a growth of 14.3%[28]. Store Operations - As of September 30, 2025, the total number of stores was 4,675, a net decrease of 560 stores compared to the same period last year, with franchise stores decreasing by 380 and self-operated stores increasing by 47[15]. Accounting and Auditing - The company has not audited its third-quarter financial report[34]. - The company plans to implement new accounting standards starting from 2025[34].

Financial Performance - The company's revenue for Q3 2025 reached ¥745,316,863.66, representing a year-on-year increase of 12.23%[5] - Net profit attributable to shareholders was ¥165,362,122.09, up 5.39% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥155,919,411.38, an increase of 11.24% year-on-year[5] - Total operating revenue for the current period reached ¥2,143,361,604.63, an increase of 13.6% compared to ¥1,886,467,590.48 in the previous period[21] - Net profit for the current period was ¥500,964,846.15, representing a 17.9% increase from ¥424,529,434.81 in the previous period[22] - Earnings per share (EPS) for the current period was ¥0.98, compared to ¥0.82 in the previous period, indicating a growth of 19.5%[23] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥8,174,351,580.45, reflecting a 7.69% increase from the end of the previous year[5] - The total assets increased to ¥8,174,351,580.45 from ¥7,590,678,002.43, marking a rise of 7.7%[19] - Non-current assets totaled ¥2,384,555,685.34, up from ¥2,134,818,740.07, reflecting an increase of 11.7%[19] - Current liabilities rose to ¥1,208,795,573.94 from ¥918,924,004.04, an increase of 31.5%[19] - The company's total equity attributable to shareholders increased by 4.29% to ¥6,292,938,353.24 compared to the end of the previous year[5] - The company's total equity increased to ¥6,674,707,297.86 from ¥6,384,523,865.92, showing a growth of 4.5%[19] Cash Flow - Cash flow from operating activities for the year-to-date was ¥624,876,010.75, showing a decrease of 14.53%[5] - Operating cash flow for the current period is ¥624,876,010.75, a decrease of 14.5% from ¥731,086,850.39 in the previous period[24] - The company’s cash flow from operating activities totaled ¥2,087,023,761.26, slightly down from ¥2,103,065,489.88 in the previous period[24] - Total cash inflow from investment activities decreased significantly to ¥3,944,101,728.33 from ¥9,349,753,483.57, representing a decline of 57.8%[25] - Net cash flow from investment activities is -¥122,552,984.89, an improvement compared to -¥1,345,125,532.08 in the previous period[25] - Cash outflow from financing activities totaled ¥216,442,200.78, down from ¥359,147,200.29 in the previous period, indicating a reduction of 39.6%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 23,367[13] - The largest shareholder, Hebei Semiconductor Research Institute, holds 54.41% of shares, totaling 245,418,282 shares[13] Inventory and Receivables - Accounts receivable rose to ¥1,099,241,275.23 from ¥849,419,085.95, indicating an increase of about 29.39%[17] - Inventory increased to ¥759,899,577.20 from ¥711,380,194.55, showing a growth of approximately 6.8%[17] - The total current assets at the end of the reporting period amounted to ¥5,789,795,895.11, up from ¥5,455,859,262.36, representing an increase of about 6.1%[17] Other Financial Metrics - Research and development expenses for the current period were ¥237,783,572.41, compared to ¥203,247,307.75 in the previous period, an increase of 16.9%[21] - Deferred income tax assets rose to ¥25,351,781.70 from ¥13,995,929.73, indicating a significant increase of 81.5%[19] - The company reported a significant increase in prepayments by 319.55%, totaling ¥36,905,875.83, mainly due to increased advance payments for goods[9] - The company experienced a 49.54% increase in accounts payable, amounting to ¥790,623,828.05, primarily due to increased material payments[9] Corporate Governance - The company held a temporary shareholders' meeting on September 15, 2025, to approve the addition of one employee director to the board, increasing the total number of board members to 12[16] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending[14] - There were no changes reported regarding the top 10 shareholders' participation in securities lending activities[14] - The company has not disclosed any significant new product developments or market expansion strategies in the current reporting period[15]

Financial Performance - The company's revenue for Q3 2025 reached ¥501,511,963.83, representing a year-on-year increase of 21.09%[5] - Net profit attributable to shareholders was ¥70,921,966.99, up 31.75% compared to the same period last year[5] - The basic earnings per share increased by 31.58% to ¥0.150[5] - The company reported a 40.76% increase in total profit, amounting to ¥239,859,285.90, driven by revenue growth in membrane products and separation engineering[8] - The comprehensive income attributable to the parent company was ¥180,988,214.13, a 48.28% increase year-on-year[8] - Net profit for the period was ¥202,899,781.94, reflecting a 30.61% increase due to higher revenue from membrane products[8] - Total operating revenue for Q3 2025 reached ¥1,381,798,675.65, an increase of 19.7% compared to ¥1,154,223,317.15 in the same period last year[18] - Net profit for the period was ¥202,899,781.94, representing a 30.6% increase from ¥155,353,722.76 in the previous year[19] - The total comprehensive income for the period was CNY 188,543,479.03, compared to CNY 126,226,774.77 in the previous period, representing an increase of approximately 49.4%[20] - Basic and diluted earnings per share increased to 0.413 from 0.320, reflecting a growth of 29.1%[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,837,380,159.02, reflecting a 1.95% increase from the end of the previous year[5] - Total assets increased to ¥2,837,380,159.02, a rise of 1.9% compared to ¥2,783,211,613.47[16] - Total liabilities decreased to ¥667,941,227.56, down 8.7% from ¥731,381,622.70 year-over-year[16] - The company's retained earnings increased to ¥1,157,221,739.55 from ¥1,031,352,519.18, reflecting a growth of 12.2%[16] Cash Flow - The net cash flow from operating activities decreased by 56.67% to ¥121,955,659.40, attributed to higher cash payments for goods and services[9] - Net cash flow from operating activities was CNY 121,955,659.40, down from CNY 281,455,321.52, indicating a decrease of approximately 56.5%[23] - Cash inflow from operating activities totaled CNY 1,133,132,458.27, while cash outflow was CNY 1,011,176,798.87, resulting in a net cash flow from operating activities of CNY 121,955,659.40[23] - Investment activities resulted in a net cash outflow of CNY 13,295,325.88, compared to a net outflow of CNY 25,095,930.11 in the previous period, indicating an improvement[23] - Financing activities generated a net cash outflow of CNY 75,600,296.67, compared to a net outflow of CNY 45,763,453.41 in the previous period, reflecting a decline in cash flow from financing[23] - The company received CNY 7,495,000.00 in cash from investment income, up from CNY 6,844,271.50 in the previous period, marking an increase of approximately 9.5%[23] - The company reported a tax refund of CNY 256,791.34, a significant decrease from CNY 9,957,387.01 in the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 30,165[10] - The largest shareholder, CRRC Industry Investment Co., Ltd., holds 45.42% of the shares, totaling 214,662,759 shares[10] - The top ten shareholders hold a combined 55.64% of the shares, indicating a concentrated ownership structure[10] - The company has no preferred shareholders or related transactions reported for the period[11] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending[10] Corporate Governance - The company has canceled its supervisory board, transferring its powers to the audit committee of the board of directors[11] - The company has appointed a new director, replacing the previous director who resigned due to work changes[11] Investments and Projects - The company plans to invest in a membrane material and membrane component capacity enhancement project, with the total investment amount subject to internal approval and market risks[12] - The company has signed a procurement contract for a wastewater reuse membrane concentration project with a total amount of RMB 5,200,000[12] - A profit distribution plan was approved, with a dividend of RMB 0.6 per 10 shares based on a total share capital of 472,621,118 shares[12] Accounts Receivable and Inventory - Accounts receivable rose by 32.70% to ¥312,931,579.16 due to increased project revenue during the reporting period[8] - Accounts receivable rose to ¥312,931,579.16, up 32.7% from ¥235,816,057.82 year-over-year[15] - Inventory decreased to ¥212,478,950.34, down 11.2% from ¥239,284,845.33 in the previous year[15] Research and Development - Research and development expenses for the period were ¥79,804,002.89, an increase of 12.5% compared to ¥71,092,837.23 in the previous year[19] Mergers and Acquisitions - The company did not conduct any mergers or acquisitions during the reporting period, focusing instead on internal growth strategies[24]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥439,266,499.08, representing a year-on-year increase of 19.17%[3] - Total profit for the quarter was ¥122,895,837.62, a significant increase of 107.03% compared to the same period last year[3] - Net profit attributable to shareholders was ¥102,650,018.83, reflecting a year-on-year growth of 98.82%[3] - The basic earnings per share for the quarter was ¥0.31, up 106.67% from the previous year[3] - The company reported a total profit for the year-to-date period of ¥351,842,561.96, which is a 42.61% increase compared to the same period last year[3] - Net profit for the first three quarters of 2025 was ¥302,378,722.27, representing a 38.93% increase from ¥217,596,363.37 in 2024[19] - Earnings per share for the first three quarters of 2025 were ¥0.90, compared to ¥0.64 in the same period of 2024, marking a 40.63% increase[20] Research and Development - Research and development expenses totaled ¥20,188,366.95, accounting for 4.60% of operating revenue, an increase of 0.76 percentage points year-on-year[4] Assets and Liabilities - The company's total assets as of the end of the reporting period were ¥6,179,608,442.93, a slight increase of 0.95% from the end of the previous year[4] - Total current assets as of September 30, 2025, amount to RMB 3,757,457,530.89, an increase from RMB 3,682,834,689.23 as of December 31, 2024[14] - Total assets as of September 30, 2025, are RMB 6,179,608,442.93, compared to RMB 6,121,583,989.79 at the end of 2024[15] - Total liabilities as of September 30, 2025, amount to RMB 1,316,844,207.06, down from RMB 1,584,686,944.92 at the end of 2024[15] - The total liabilities as of the latest reporting period amounted to ¥1,766,479,509.63, a decrease from ¥2,013,617,141.96 in the previous year[16] - Total non-current liabilities were ¥449,635,302.57, up from ¥428,930,197.04, indicating a growth of 4.88%[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,881[11] - The largest shareholder, Sanda Membrane Technology (Singapore) Co., Ltd., holds 144,770,450 shares, representing 43.60% of total shares[11] - The company has no significant changes in the shareholding structure among the top 10 shareholders[12] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥147,219,383.11, showing a substantial increase of 133.82%[3] - Cash flow from operating activities for the first three quarters of 2025 was ¥834,168,085.99, significantly higher than ¥605,980,173.85 in 2024[22] - Operating cash inflow totaled $875,061,310.05, an increase from $638,054,620.62 year-over-year[23] - Operating cash outflow amounted to $727,841,926.94, compared to $575,093,242.09 in the previous period[23] - Net cash flow from operating activities was $147,219,383.11, up from $62,961,378.53 year-over-year[23] Investment Activities - Cash inflow from investment activities reached $1,066,978,569.73, down from $1,389,283,416.21[23] - Cash outflow from investment activities was $1,226,331,336.14, compared to $1,527,091,065.92 in the previous period[23] - Net cash flow from investment activities was -$159,352,766.41, worsening from -$137,807,649.71 year-over-year[23] - Investment income for the first three quarters of 2025 was ¥40,507,703.72, compared to ¥36,434,044.98 in 2024, showing an increase of 18.56%[19] - The company reported a decrease in credit impairment losses from -¥39,782,603.30 in 2024 to -¥18,512,517.12 in 2025, indicating improved asset quality[19] Financing Activities - Cash inflow from financing activities totaled $1,800,000.00, with no previous period data available[24] - Cash outflow from financing activities was $32,635,318.53, down from $48,187,139.42[24] - Net cash flow from financing activities was -$30,835,318.53, compared to -$48,187,139.42 in the previous period[24] - The ending cash and cash equivalents balance was $506,041,606.09, down from $549,927,538.02 year-over-year[24] Equity - The total equity attributable to shareholders of the parent company increased to ¥4,347,061,880.10 from ¥4,047,350,773.26, reflecting a growth of 7.41%[16]

Financial Performance - The company's revenue for Q3 2025 was ¥2,876,338,957.63, a decrease of 4.71% compared to the same period last year[5] - Net profit attributable to shareholders was ¥67,972,557.71, down 37.27% year-on-year[5] - The basic earnings per share decreased by 37.87% to ¥0.0274[5] - Total revenue for the period reached ¥8,958,174,381.73, an increase of 3.7% compared to ¥8,637,021,595.79 in the previous period[21] - The net profit for Q3 2025 was CNY 291,877,683.28, a decrease of 10.0% compared to CNY 324,254,411.64 in the same period last year[22] - Operating profit for the quarter was CNY 313,741,822.71, down from CNY 322,209,414.09, reflecting a decline of 2.9% year-over-year[22] - The company reported a total comprehensive income of CNY 291,798,695.44, compared to CNY 324,202,644.26 in the previous year, indicating a decrease of 10.0%[22] - Basic and diluted earnings per share were both CNY 0.1159, slightly down from CNY 0.1193 in the same quarter last year[23] Assets and Liabilities - Total assets increased by 13.44% to ¥18,411,126,227.59 compared to the end of the previous year[5] - Total liabilities increased to ¥9,124,740,924.17 from ¥7,372,428,711.58, a rise of 23.8%[20] - The company's equity attributable to shareholders rose to ¥8,738,625,151.76 from ¥8,315,026,402.10, an increase of 5.1%[21] - Non-current assets totaled ¥9,196,962,963.05, up from ¥8,697,083,192.56, reflecting an increase of 5.7%[20] Cash Flow - Cash flow from operating activities for the year-to-date increased by 163.70% to ¥368,255,754.70[5] - The cash flow from operating activities generated a net amount of CNY 368,255,754.70, a significant recovery from a negative cash flow of CNY -578,085,820.57 in the same quarter last year[24] - Cash and cash equivalents at the end of the period totaled CNY 1,536,702,130.91, an increase from CNY 1,060,976,113.47 at the end of the previous year[24] - The company experienced a net cash outflow from investing activities of CNY -727,124,482.61, compared to CNY -803,474,320.39 in the same period last year[24] - The net cash inflow from financing activities was CNY 689,386,430.21, down from CNY 1,140,062,857.39 in the previous year[24] Expenses - The company’s management expenses increased by 35.14% due to higher employee compensation costs[10] - Research and development expenses for the period were ¥366,582,865.63, compared to ¥335,066,555.39 in the previous period, showing an increase of 9.4%[21] - The company reported a tax expense of CNY 20,966,045.48, compared to a tax benefit of CNY -4,156,510.77 in the same quarter last year[22] Investments - The company’s investment income decreased by 58.61% year-on-year, primarily due to reduced equity method investment income from associates[10] - The company reported a net investment income of ¥15,250,626.96, down from ¥36,849,040.97, indicating a decrease of 58.7%[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 124,696[12] - Wuhu Tieyuan Investment Co., Ltd. holds 10.87% of shares, totaling 271,497,707 shares[12] - Xinjiang Runfeng Equity Investment Enterprise holds 6.89% of shares, totaling 172,138,590 shares, with 96,125,000 shares pledged[12] - The repurchase special securities account holds 20,752,600 shares, accounting for 0.83% of total shares[15] Business Development - Longxin Intelligent Computing has achieved revenue exceeding 60 million RMB, focusing on three core areas: equipment assembly, maintenance, and leasing services[16] - Longxin Intelligent Computing plans to enhance its service capabilities and expand into AI model application solutions for various industries[17] - The company aims to build a comprehensive service capability in the intelligent computing industry, integrating hardware supply, operation services, and industry applications[17] Other Financial Metrics - The company reported a 106.72% increase in credit impairment losses compared to the same period last year[10] - The company’s contract assets increased by 93.90% compared to the beginning of the year, indicating higher uncollected receivables[9] - The company's cash received from other operating activities increased by ¥83,837,500 compared to the same period last year[10] - Accounts receivable rose significantly to ¥4,517,280,338.14, compared to ¥3,565,949,332.31, marking an increase of 26.7%[19] - Inventory levels increased to ¥1,507,032,591.31 from ¥1,312,232,538.30, indicating a growth of 14.8%[19]

证券代码：002222 证券简称：福晶科技 公告编号：2025-027 福建福晶科技股份有限公司 2025年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季 度报告中财务信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计：□是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据：□是 否 | | | 本报告期 | | 年初至报告 | | | --- | --- | --- | --- | --- | --- | | | 本报告期 | 比上年同 | 年初至报告期末 | 期末比上年 | | | | | 期增减 | | 同期增减 | | | 营业收入（元） | 323,098,372.81 | 43.21% | 842,161,743.96 | 26.62% | | | 归属 ...

证券代码：300790 证券简称：宇瞳光学 公告编号：2025-071 东莞市宇瞳光学科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 东莞市宇瞳光学科技股份有限公司 2025 年第三季度报告 3.第三季度财务会计报告是否经过审计 □是 ☑否 1 东莞市宇瞳光学科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入（元） | 946,364,017.59 | 27 ...

Financial Performance - Revenue for Q3 reached ¥703,930,038.76, an increase of 81.85% year-over-year, and a total of ¥1,834,989,900.54 for the year-to-date, up 41.09%[5] - Net profit attributable to shareholders was ¥81,648,643.71, a significant increase of 200.55% compared to the same period last year, with a year-to-date total of ¥188,377,164.90, up 504.80%[5] - Basic earnings per share for Q3 were ¥0.1487, reflecting a 200.54% increase year-over-year, and ¥0.3431 year-to-date, up 504.60%[5] - Total operating revenue for the period reached ¥1,834,989,900.54, an increase of 41% compared to ¥1,300,589,458.44 in the previous period[18] - Operating profit improved significantly to ¥211,356,312.86, compared to a loss of ¥66,118,662.75 in the previous period[19] - Net profit for the period was ¥185,455,806.30, recovering from a net loss of ¥48,429,564.86 in the previous period[19] - The total comprehensive income for the period was ¥185,455,806.30, compared to a loss of ¥48,429,564.86 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,910,632,039.63, representing a 7.51% increase from the end of the previous year[5] - Total assets increased to ¥4,910,632,039.63, up from ¥4,567,421,038.41 in the previous period, reflecting a growth of approximately 7.5%[17] - Total liabilities rose to ¥1,745,982,640.87, compared to ¥1,568,641,173.71 in the previous period, marking an increase of about 11.3%[17] - The company's equity attributable to shareholders increased to ¥2,998,008,292.98, up from ¥2,829,250,904.72, representing a growth of approximately 6%[17] Cash Flow - Cash flow from operating activities showed a net outflow of ¥4,440,972.11, a decrease of 98.39% year-to-date[5] - Operating cash inflow for the current period was CNY 1,587,243,304.58, an increase of 50.4% compared to CNY 1,054,646,508.54 in the previous period[20] - Net cash flow from operating activities was negative CNY 4,440,972.11, improving from negative CNY 275,362,458.56 in the previous period[20] - Financing cash inflow was CNY 32,224,185.14, significantly up from CNY 3,758,301.99 in the previous period[21] - Net cash flow from financing activities was CNY 6,573,373.77, a recovery from negative CNY 30,618,106.74 in the previous period[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 36,395[11] - The largest shareholder, Shanxi Xinhua Protective Equipment Co., holds 18.06% of shares, totaling 99,138,233 shares[11] - The company has a total of 99,138,233 unrestricted shares held by Shanxi Xinhua Protective Equipment Co.[12] Operational Efficiency - The company has established a new procurement center and restructured several departments to enhance operational efficiency[13] - The company reported a significant increase in total profit of ¥27,298,000, up 478.72% year-over-year, driven by increased revenue and product gross margin[8] Accounts Receivable and Payable - Accounts receivable increased by ¥376,650,000, a rise of 55.86%, primarily due to increased specialized product payments[8] - Accounts receivable increased to 1,050,969,065.54 RMB from 674,316,361.81 RMB, reflecting a growth of approximately 55.6%[15] - The company reported a significant increase in accounts payable, which rose to ¥768,529,669.75 from ¥658,813,482.31, reflecting a growth of approximately 16.7%[17] Inventory and Fixed Assets - Inventory rose to 404,910,544.17 RMB, up from 353,947,599.58 RMB, indicating an increase of about 14.4%[15] - The company’s fixed assets decreased to 818,475,295.55 RMB from 872,733,325.55 RMB, a decline of approximately 6.2%[15] Research and Development - Research and development expenses for the period were ¥89,328,187.95, compared to ¥74,965,532.83 in the previous period, indicating a 19% increase[18]